• 产品
  • 供应商
  • CAS号
  • 采购
  • 资讯
  • 会展活动

您的位置:首页 >> 制药产品大全 >> 原料药 >> Glimepiride Tablets (Dibei ®)

Glimepiride Tablets (Dibei ®)

Glimepiride Tablets (Dibei ®)

更新时间:2023-05-11
CAS号:--
药典:企业标准
级别:药用级
详细描述
  • 主要销售市场:北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲
  • 提供样品:
产品描述:

Introduction: in September 2001, the domestic glimepiide tablet dibei was approved by the state drug administration and it belongs to the second class new drug in the country, and began to be sold in the domestic market in November.It has been well received by clinical experts and patients since its sale for 3 years.

 

Indications: Type 2 diabetes.

 

Usage and dosage: refer to instructions or doctor's advice for details

 

Adverse Reaction: See the instructions for details

 

Contraindications: It is contraindicated in people with known allergy to any ingredient in glimepiride, other sulfonylureas, sulfonamides or excipients;It is contraindicated for patients with previous ketoacidosis, diabetic ketoacidosis, pre-diabetic coma or diabetic coma;Patients with severe liver and renal function impairment are contraindicated.Pregnant and lactating patients are prohibited;

 

Precautions: See the instructions for details

地址:

城市:

联系人:

电话:

传真:

成为供应商 在线获取商机 申请入驻
快速询盘
原料药
CPHI制药在线为您找到Glimepiride Tablets (Dibei ®)价格、Glimepiride Tablets (Dibei ®)详细参数、Glimepiride Tablets (Dibei ®)相关产品、Glimepiride Tablets (Dibei ®)供应商等信息,想了解当前Glimepiride Tablets (Dibei ®)最新报价,请联系北京北陆药业股份有限公司
CPHI 网上贸易平台: CPHI.cn| Pharmasources.com| CPHI-Online.com
客服热线:  86-400 610 1188 (周一至周五 9: 00-18: 00)